XBiotech Inc. Files Q1 2025 10-Q
Ticker: XBIT · Form: 10-Q · Filed: May 14, 2025 · CIK: 1626878
| Field | Detail |
|---|---|
| Company | Xbiotech Inc. (XBIT) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financial-reporting
TL;DR
XBiotech Q1 2025 10-Q filed. Financials and operations update.
AI Summary
XBiotech Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and business operations for the first quarter of 2025. Key financial data and operational updates are presented, reflecting the company's status in the pharmaceutical preparations sector.
Why It Matters
This filing provides investors and stakeholders with an update on XBiotech's financial health and strategic direction for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, XBiotech faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- XBiotech Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250514 (date) — Filing date
- 512-386-2900 (phone_number) — Company business phone
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 14, 2025.
What is XBiotech Inc.'s Standard Industrial Classification code?
XBiotech Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the business address of XBiotech Inc.?
The business address of XBiotech Inc. is 5217 Winnebago Lane, Austin, TX 78744.
What is the SEC file number for XBiotech Inc.?
The SEC file number for XBiotech Inc. is 001-37347.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding XBiotech Inc. (XBIT).